Crinetics Pharmaceuticals, Inc. logo

CRNXCrinetics Pharmaceuticals, Inc.

CRNX Stock Price, Valuation & Chart | Crinetics Pharmaceuticals, Inc.

Compare

CRNX Historical price chart

CRNX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization9.00B
PE Ratio-16.86
EPS-5.04
Trading Volume8.18M
Today's High/Low85.03/84.92
Dividend Yield0.00
52 Week High/Low85.01/31.0
Shares Outstanding105.97M
CRNX Financial Statement
CRNX Analyst ratings
CRNX Analysis & performance metrics

CRNX Company profile

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine…

CRNX Management team

Management
Stephen F. Betz Ph.D.
Co-Founder & Chief Scientific Officer
Gayathri Diwakar
Head of Investor Relations
Jeff E. KnightCOO
Chief Operating Officer
Adriana Cabre M.B.A.
Chief Human Resources Officer
R. Scott Struthers Ph.D.CEO
Founder, President, Chief Executive Officer & Director
Dana Pizzuti M.D.
Chief Medical & Development Officer
Alan S. Krasner M.D.
Chief Endocrinologist
Kevin Capps
Head of Intellectual Property
Total 8 executives

CRNX Frequently asked questions

What is Crinetics Pharmaceuticals, Inc. (CRNX) Stock Price?

Current stock price of Crinetics Pharmaceuticals, Inc. (CRNX) stock is $84.950. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Crinetics Pharmaceuticals, Inc. (CRNX) stock is 8.18M.

Last updated at 31 Aug 2026, 08:00 pm.

Why is the Crinetics Pharmaceuticals, Inc. (CRNX) stock price going up or down today?

The stock price of Crinetics Pharmaceuticals, Inc. (CRNX) can change with earnings, company news, and overall market sentiment. Crinetics Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Crinetics Pharmaceuticals, Inc. stock expensive at its current price?

Whether Crinetics Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRNX on this page is -16.86. EPS on this page is -5.04. Compare those figures with peers and growth expectations before deciding if the current Crinetics Pharmaceuticals, Inc. price is justified.

How has the stock price of Crinetics Pharmaceuticals, Inc. (CRNX) performed historically?

Historical performance for Crinetics Pharmaceuticals, Inc. (CRNX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRNX reacted to past earnings and market events.

Should I buy Crinetics Pharmaceuticals, Inc. (CRNX) stock, at this price?

Buying Crinetics Pharmaceuticals, Inc. (CRNX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.